Navigation Links
BD Pathway 435 confocal bioimager from BD Biosciences - Bioimaging

ProductsBD Pathway 435 confocal bioimager from BD Biosciences - Bioimaging
Company BD Biosciences - Bioimaging
Item BD Pathway 435 confocal bioimager
Price 
Description The BD Pathway 435 is an affordable, compact benchtop imager compatible with multiwell plates and slides, providing a broad array of automated imaging capabilities. The system rapidly acquires high-resolution images with high-performance laser autofocus, true confocal optics, flexible computer-controlled excitation and emission filter changers, and a long-life alignment-free metal halide lamp.

With updated image analysis software featuring new tools and wizard-style applications, the BD Pathway 435 confocal bioimager simplifies the process of high-content cellular analysis.

The system enables a broad array of fluorescence-based biological applications* such as neurite outgrowth analysis, angiogenesis, protein translocation, colocalization, cell cycle, and 3-dimensional cellular exploration. The BD Pathway 435 is ideal for researchers that need high-speed, high-resolution confocal imaging capabilities coupled with powerful and flexible image analysis.



  • High-performance, laser-based autofocus is standard. You can elect to use the laser autofocus, camera autofocus, or a combination of both.
  • Robot-compatible, retractable plate tray permits imaging even in well-lit laboratories.
  • Transmitted light canopy provides illumination for brightfield imaging.
  • User accessible filters allow easy filter wheel exchange for a broader range of imaging options and customization.
  • The Pathway 435 adds BDs proprietary spinning disk confocal capability and associated 3D imaging software.
  • High quantum efficiency cooled 12 bit CCD camera produces high resolution images for analysis.
  • Flexible illumination using 8 excitation, 8 emission, and 5 dichroic filters that are all independently controlled.
  • Compact unit with integrated electronics and vibration dampening system sits on top of a laboratory bench.
  • Accurate x, y, z positioning provides an optimal environment for precision imaging.
Info BD Biosciences - BioimagingBD Biosciences - Bioimaging
15010 Broschart Road
Rockville, MD 20850
USA
Customer Service: +1 800 245-2614
Fax Number: +1 301 340-9775
Web Site: http://www.bdbiosciences.com/bioimaging
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Pathway Studio Enterprise from Ariadne Genomics
2. BD Pathway 415 bioimager from BD Biosciences - Bioimaging
3. BD Pathway Bioimager from BD Biosciences - Bioimaging
4. Apoptosis Pathway SpliceArrays from ExonHit Therapeutics Inc.
5. Mouse cAMP / Ca2+ Signaling PathwayFinder, PCR Array for expression profiling from SuperArray Bioscience
6. Mouse NFkB Signaling Pathway, PCR Array for expression profiling from SuperArray Bioscience
7. Rat NFkB Signaling Pathway, PCR Array for expression profiling from SuperArray Bioscience
8. Rat Signal Transduction PathwayFinder, PCR Array for expression profiling from SuperArray Bioscience
9. Mouse Anti-Mouse Glutathione S-transferase M1 (GSTM1) Monoclonal Antibody, Unconjugated from Lifespan Biosciences
10. Rabbit Anti-Human Vitamin K-dependent Protein S (PROS1) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
11. Rabbit Anti-Human Sirtuin (silent mating type information regulation 2, S.cerevisiae, homolog) 7 (SIRT7) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
Tube-O-DIALYZER Floats, small....
Nestin, Human...
Rabbit polyclonal to Survivin DEx3 ( Abpromise for all tested applications). entrezGeneID: 332 SwissProtID: O15392...
Smac/DIABLO (mouse) (CT) rabbit polyclonal antibody...
Biology Products:
(Date:12/3/2014)... , Dec. 2, 2014   Marvin Test ... innovative test solutions for military, aerospace, and manufacturing ... of its successful TS-900 PXI semiconductor test ... features of high-end systems to customers at a ... compared to traditional ATE. "Our ...
(Date:11/21/2014)... According to a new market research report ... Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), End ... - Global Forecasts to 2020", published by MarketsandMarkets, The ... $25 Billion in 2014 and is expected to reach ... 8.69%. Browse 116 market data Tables and ...
(Date:11/21/2014)... VIEW, Calif. , Nov. 20, 2014 ... higher driver efficiency are piloting the North American and ... number of accidents growing, gesture recognition systems that are ... make a mark in the industry. ... the Automotive Gesture Recognition Market in Europe ...
Breaking Biology News(10 mins):Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4
... ,Global chemical companies could release at least one billion ... performance. The claim has been made following ... nine global chemical companies in monetary terms. Entitled Sustainable ... by a leading European research team including academics from ...
... population carry Helicobacter pylori ( H. pylori ) ... population are infected. Besides cancer, these bacteria are linked to ... the H. pylori genome in 1997 revealed this ... a number of crucial questions: Where do the genes of ...
... 3025 MONALISA has developed a new, completely natural alternative to ... and to prevent the damaging effects of the fungal toxins ... for use in animal feed in the EU since 2006 ... The already-known capacity of clay minerals to adsorb these mycotoxins ...
Cached Biology News:Study highlights sustainable footprint of chemical companies 2Study highlights sustainable footprint of chemical companies 3Gene regulation: Can we stomach it? 2French and Spanish researchers develop a natural alternative to antibiotics in animal feed 2French and Spanish researchers develop a natural alternative to antibiotics in animal feed 3
(Date:12/17/2014)... Ipsen Biopharmaceuticals, Inc., an affiliate ... IPSEY), today announced that Somatuline® Depot® (lanreotide) ... approved by the U.S. Food and Drug Administration ... (GEP-NETs) in adult patients with unresectable, well or ... improve progression-free survival (PFS). , “The approval of ...
(Date:12/17/2014)... 17, 2014 Gene synthesis and ... has entered into a technology access and services ... apply DNA2.0’s proprietary protein engineering technology, known as ... “We are extremely excited that the global leader ... This proprietary bioengineering technology has now been validated ...
(Date:12/17/2014)... , Dec. 17, 2014 CASI Pharmaceuticals, Inc. ... to the acquisition, development and commercialization of innovative therapeutics ... global market with a primary commercial focus on ... been granted a Type C meeting with the U.S. ... will be held in February 2015.  During this meeting ...
(Date:12/15/2014)... & PETACH TIKVAH, Israel , Dec. ... BCLI ), a leading developer of adult stem ... subsidiary Brainstorm Cell Therapeutics Ltd. was awarded a grant ... Office of the Chief Scientist (OCS).  This is ... of grant support from the Office of the Chief ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3